Cite Filings / VNDA / 0001628280-26-026893

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Vanda Pharmaceuticals Inc. Filed 2026-04-23 Acc 0001628280-26-026893

Documents 1

DEF 14A Proxy Statement , vnda-20260423.htm

Around this filing

2026-04-24 4 Director acquired 57,101 shares (grant or award)
2026-04-24 CORRESP Correspondence Between Filers and SEC Staff
2026-04-23 ARS Annual Report to Security Holders
2026-04-23 DEFA14A Proxy Materials
2026-04-23 DEF 14A Proxy Statement
2026-04-22 8-K Executive or director change
2025-04-25 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading vnda-20260423.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…